1. Home
  2. NBTX vs SPPP Comparison

NBTX vs SPPP Comparison

Compare NBTX & SPPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTX
  • SPPP
  • Stock Information
  • Founded
  • NBTX 2003
  • SPPP 2011
  • Country
  • NBTX France
  • SPPP Canada
  • Employees
  • NBTX N/A
  • SPPP N/A
  • Industry
  • NBTX Biotechnology: Pharmaceutical Preparations
  • SPPP
  • Sector
  • NBTX Health Care
  • SPPP
  • Exchange
  • NBTX Nasdaq
  • SPPP NYSE
  • Market Cap
  • NBTX 211.9M
  • SPPP 172.2M
  • IPO Year
  • NBTX 2020
  • SPPP N/A
  • Fundamental
  • Price
  • NBTX $4.57
  • SPPP $11.77
  • Analyst Decision
  • NBTX Strong Buy
  • SPPP
  • Analyst Count
  • NBTX 1
  • SPPP 0
  • Target Price
  • NBTX $8.00
  • SPPP N/A
  • AVG Volume (30 Days)
  • NBTX 7.1K
  • SPPP 183.3K
  • Earning Date
  • NBTX 04-02-2025
  • SPPP 01-01-0001
  • Dividend Yield
  • NBTX N/A
  • SPPP N/A
  • EPS Growth
  • NBTX N/A
  • SPPP N/A
  • EPS
  • NBTX N/A
  • SPPP N/A
  • Revenue
  • NBTX N/A
  • SPPP N/A
  • Revenue This Year
  • NBTX N/A
  • SPPP N/A
  • Revenue Next Year
  • NBTX $221.06
  • SPPP N/A
  • P/E Ratio
  • NBTX N/A
  • SPPP N/A
  • Revenue Growth
  • NBTX N/A
  • SPPP N/A
  • 52 Week Low
  • NBTX $2.76
  • SPPP $8.55
  • 52 Week High
  • NBTX $6.00
  • SPPP $11.39
  • Technical
  • Relative Strength Index (RSI)
  • NBTX 52.43
  • SPPP 62.61
  • Support Level
  • NBTX $4.31
  • SPPP $11.57
  • Resistance Level
  • NBTX $5.00
  • SPPP $12.36
  • Average True Range (ATR)
  • NBTX 0.26
  • SPPP 0.27
  • MACD
  • NBTX -0.06
  • SPPP -0.02
  • Stochastic Oscillator
  • NBTX 24.44
  • SPPP 50.57

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

About SPPP SPROTT PHYS PLATINUM & PALLADIUM

Sprott Physical Platinum & Palladium Tr invests and holds all of its assets in physical platinum and palladium bullion. The company seeks to provide a secure, convenient, and exchange-traded investment alternative for investors interested in holding physical platinum and palladium bullion without the inconvenience that is typical of a direct investment in physical bullion. The Trust invests mainly in long-term holdings of unencumbered, fully allocated, physical platinum and palladium bullion.

Share on Social Networks: